TickerFactsScreenerDevelopers

Axsome Therapeutics, Inc. (AXSM) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$2.03M2014: -$3.20M2015: $46.44M2016: $21.57M2017: $16.72M2018: $937.9K2019: $178.72M2020: $113.79M2021: $15.63M2022: $109.56M2023: $190.98M2024: $57.02M2025: $88.30M$88.30M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$88.30M+54.9%
2024$57.02M-70.1%
2023$190.98M+74.3%
2022$109.56M+600.9%
2021$15.63M-86.3%
2020$113.79M-36.3%
2019$178.72M+18955.2%
2018$937.9K-94.4%
2017$16.72M-22.5%
2016$21.57M-53.6%
2015$46.44M+1550.2%
2014-$3.20M-57.9%
2013-$2.03M—